Industries
Solutions
Capabilities
About
Insights
Accelerating the time to market for a novel ophthalmic implant drug.
Sanner partnered with an ocular therapeutics company to develop a fully custom injection device capable of delivering an extended-release pharmaceutical implant into the vitreous for the treatment of wet age-related macular degeneration and glaucoma.
The client required a device that could reliably and safely deliver a novel pharmaceutical implant into the delicate ocular environment while meeting regulatory, human factors, and manufacturability requirements.
When the project began, Sanner dove in with concept development and rigorous proof-of-concept testing, shaping the vision for the new device. Once the initial ideas were validated, the team conducted a thorough IP Landscape Review and charted a clear pathway to bring the combination product to market. Drawing on ophthalmic drug delivery expertise, Sanner designed a custom needle assembly, including the hub, needle, and cap, tailored to the client’s needs. To support early research, they then manufactured a small batch of over a thousand units, enabling critical toxicology testing and Human Factors KOL (Key Opinion Leaders) study.
A fully custom ocular injector, compatible with a novel pharmaceutical implant, now ready for further commercialization and integration into clinical use.
End-to-end development and manufacturing for a product that helps surgeons collect and use bone for grafting.
Robust development of a next generation platform autoinjector.
Designing and building a demonstrator to show the effectiveness of a next-generation autoinjector platform.
Developing a closed system transfer device that protects clinicians from hazardous drugs without slowing them down.
